Alternative splicing of class 1 mRNA in lymphoblastoid cell lines, PBL and tissues

被引：0
|
作者：
Drouet, M [1 ]
机构：
[1] FAC MED,LAB IMMUNOL & IMMUNOGENET,LIMOGES,FRANCE
来源：
HUMAN IMMUNOLOGY | 1996年 / 47卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：P52 / P52
页数：1
相关论文
共 50 条
  • [1] Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines
    Duan, Shiwei
    Huang, R. Stephanie
    Zhang, Wei
    Mi, Shuangli
    Bleibel, Wasim K.
    Kistner, Emily O.
    Cox, Nancy J.
    Dolan, M. Eileen
    PHARMACOGENOMICS, 2009, 10 (04) : 549 - 563
  • [2] Alternative splicing of the K-ras gene in mouse tissues and cell lines
    Wang, Y
    You, M
    Wang, Y
    EXPERIMENTAL LUNG RESEARCH, 2001, 27 (03) : 255 - 267
  • [3] Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines
    Weng, MW
    Lai, JC
    Hsu, CP
    Yu, KY
    Chen, CY
    Lin, TS
    Lai, WW
    Lee, H
    Ko, JL
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2005, 46 (01) : 1 - 11
  • [4] Alternative mRNA splicing of RAD5 on mouse tissues
    Ozuna, Hazel
    Burke, David
    Wylie, Melissa
    Ozuna-Vazquez, Hazel
    FASEB JOURNAL, 2009, 23
  • [5] Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: Promoter usage and alternative mRNA splicing
    ShawBruha, CM
    Pirrucello, SJ
    Shull, JD
    BREAST CANCER RESEARCH AND TREATMENT, 1997, 44 (03) : 243 - 253
  • [6] Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: Promoter usage and alternative mRNA splicing
    Carla M. Shaw-Bruha
    Samuel J. Pirrucello
    James D. Shull
    Breast Cancer Research and Treatment, 1997, 44 : 243 - 253
  • [7] Detection of alternative splicing of fibronectin mRNA in a single cell
    Kumazaki, T
    Mitsui, Y
    Hamada, K
    Sumida, H
    Nishiyama, M
    JOURNAL OF CELL SCIENCE, 1999, 112 (10) : 1449 - 1453
  • [8] Alternative splicing of MDM2 mRNA in lung carcinomas and lung cell lines (vol 46, pg 1, 2005)
    Weng, MW
    Lai, JC
    Hsu, C
    Yu, KY
    Chen, CY
    Lin, TS
    Lai, WW
    Lee, H
    Ko, JL
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2005, 46 (03) : 206 - 206
  • [9] Evaluation of splicing efficiency in lymphoblastoid cell lines from patients with splicing-factor retinitis pigmentosa
    Ivings, Lenka
    Towns, Katherine V.
    Matin, M. A.
    Taylor, Charles
    Ponchel, Frederique
    Grainger, Richard J.
    Ramesar, Rajkumar S.
    Mackey, David A.
    Inglehearn, Chris F.
    MOLECULAR VISION, 2008, 14 (271-74): : 2357 - 2366
  • [10] Transcriptomic variation of pharmacogenes in multiple human tissues and lymphoblastoid cell lines
    A Chhibber
    C E French
    S W Yee
    E R Gamazon
    E Theusch
    X Qin
    A Webb
    A C Papp
    A Wang
    C Q Simmons
    A Konkashbaev
    A S Chaudhry
    K Mitchel
    D Stryke
    T E Ferrin
    S T Weiss
    D L Kroetz
    W Sadee
    D A Nickerson
    R M Krauss
    A L George
    E G Schuetz
    M W Medina
    N J Cox
    S E Scherer
    K M Giacomini
    S E Brenner
    The Pharmacogenomics Journal, 2017, 17 : 137 - 145
12345